Question 1

What is the catalog number for Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV)?

Accepted Answer

The catalog number for Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV) is GT05179.

Question 2

What sizes are available for Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV)?

Accepted Answer

Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV) is available in the following size(s): 50 µg.

Question 3

Is Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV) in stock?

Accepted Answer

Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 5

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Brilliant Violet 711™ anti-mouse CD16.2 (FcγRIV)

Product Specifications

Reactivity

Isotype

Clone

Conjugation

Applications

Specificity

Frequently Asked Questions

Explore Other Products

Smooth Muscle Myosin Heavy Chain (SM-MHC) (MYH11/2303R), CF740 conjugate, 0.1mg/mL

Tenascin C (Stromal Marker For Epithelial Malignancy) (TNC/2981R), CF568 conjugate, 0.1mg/mL

Myosin, Smooth Muscle Heavy Chain (MYH11/923), CF740 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2742), CF568 conjugate, 0.1mg/mL

Caldesmon, HMW (h-Caldesmon) (Smooth Muscle Marker) (rCALD1/820), CF568 conjugate, 0.1mg/mL

Bcl-x (BX006), CF740 conjugate, 0.1mg/mL